You just read:

Nektar Therapeutics Presents Preliminary Immune Activation, Safety and Clinical Activity Data from the Ongoing Dose-Escalation Stage of the REVEAL Study at 2019 ASCO-SITC Meeting

News provided by

Nektar Therapeutics

Mar 01, 2019, 16:40 ET